Drugs / Desloratidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01601522 | Feb 2012 → Sep 2021 | food allergy | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Desloratidine | “Desloratidine 5 ml po od (0.5mg/ml = 2.5 mg) Ranitidine 5ml (15mg/ml=75 mg) po bid” NCT01601522 ↗ |
| Route | Oral | “Desloratidine 5 ml po od (0.5mg/ml = 2.5 mg)” NCT01601522 ↗ |